← FDA Drug Approvals (Drugs@FDA)

HYPAQUE

NDA · New Drug Application · Sponsor: GE HEALTHCARE · Approved 1969-08-21

Drug application

FDA Application #

NDA016403

Application type

New Drug Application

Brand name

HYPAQUE

Generic name

Diatrizoate Meglumine

Active ingredients

DIATRIZOATE MEGLUMINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GE HEALTHCARE

First approval

1969-08-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown